Michael Bodner News Today

Johnson & Johnson (NYSE: JNJ) announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion.

Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in...

Drug major Johnson & Johnson (JNJ) announced Friday its agreement to acquire Shockwave Medical, Inc. (SWAV) for $335.00 per share in cash. The enterprise value of the deal is around $13.

Nearly a quarter of the way through 2023, we've seen plenty of movement in the personnel department across medtech.

Lynchburg City Council is beginning to announce interviewees for three seats on the Lynchburg City School Board that are set to expire on June 30, closing the application portion of

Johnson & Johnson's Biosense Webster this week announced it appointed Jasmina Brooks as president, succeeding Michael Bodner.

Lawyers for the province acknowledged the late imposition of a wage directive had an impact on negotiations and keeping it secret was inappropriate but they argued it was an error to treat the mandate as a Charter breach.

Johnson & Johnson (NYSE:JNJ) announced today that it completed its $16.6 billion acquisition of Abiomed (Nasdaq:ABMD).

Johnson & Johnson announced today that it extended the expiration date of its offer to acquire Abiomed.

Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire ...